http://www.hardmanandco.com/Research/Alliance_June2005.pdf


Web Site : http://www.alliancepharma.co.uk

http://www.hemscott.com/hstoday/Focus_2005/Alliance%20Pharma_1205_2005.htm

Hardmans late June 2005 update

Fair value at 30p

http://www.hardmanandco.com/Research/Alliance_June2005.pdf

Looks like we are hitting some profit taking here.

PpP: Have returned to find bright blue blossom covering APH and my holding now shows a 40% gain since buying only about 6 weeks ago. Would be tempted to add were there any retraction, but bid or no, this one now seems to have a real head of steam and I am looking forward to a profitable ride.
Meanwhile, my own low key enquiries among medics about Melatonin point the same way as that reported by frodo, so here's to Posidorm.
I do like your headers, which I note have spread to others of your favourites and which I continue to monitor.
sd.

squidd it does look good on the APH front. VLK is rumoured to be about to release loads of contract news next week and could be going to 45p or higher. Today UNG gave a good solid trading statement and is one to watch in the coming months for solid gains.

A very nice cross of MA50 through MA200 soon ?

A nice cross of MA50 through MA200 coming ?

squidd terrible news today its so sad !

A Golden Cross is happening and there were some big buys this morning before the sad events.

squidd Hardman June report says 30p is fair value.

http://www.hardmanandco.com/Research/Alliance_June2005.pdf

squidd from the charts lets hope for a solid rise to above 30p.

squidd are you still on holiday ? What do you think of the Hardman write up ? In my opinion Periostat will do better this year than they forecast and Posiderm will be massive for the future.

http://www.hardmanandco.com/Research/Alliance_June2005.pdf

squidd also new presentation on June 22nd 2005 to G.C.I. is available;

http://miranda.hemscott.com/ir/aph/pdf/2005_06_22_growth_company_investor.pdf

what do you think ?

PpP: As a holder of 50k shares in APH, I enjoyed reading the 2 reports. But as a layman, I cannot really comment on the potential of the new products and those under development, other than to agree in general terms about growth prospects.
In any case, I've read too many glowing analysts reports to place to much reliance on them, because at the end of the day, so much depends upon the energy and enterprise of the management team. With APH, I think they know what they are at and are making the right moves, so I'm happy to be on board
(in contrast to ELA, who I felt voiced some muddled thinking at their recent AGM).
But the reports are very positive and help confirm my own views. Additionally, the chart looks to me like a classic recovery, so I'll be looking for an sp of 30p or more by Xmas.
sd.

PpP: I had expected some profit taking here, and it may yet occur, but meanwhile I note what you say about profit taking at VLK. Encouraged by a rise in my TED holding, I will be inclined to add to APH on any dips.
sd.

squidd its very interesting so far that APH remains stable if it can keep this up the next move up will also be quick and strong when it happens. Like you if it drops I will add on the bottom of any drop.

Alliance Pharma PLC
29 July 2005

For Immediate Release 29 July 2005

ALLIANCE PHARMA PLC
('Alliance' or 'the Company')

Leading distributor signed in Turkey for Periostat(R)

Alliance Pharma plc (AIM: APH), the emerging speciality pharmaceutical company,
is pleased to announce that it has entered into a distribution agreement with
Vem IIac to register, distribute and market Periostat in Turkey. Simultaneously
to this agreement, Alliance has also extended its agreement with CollaGenex to
add Turkey to its list of available territories.

Periostat is the first and only approved prescription medicine for the treatment of the severe gum disease periodontitis.

Vem IIac, based in Ankara, is a specialist dental pharmaceutical company and is
highly experienced in the dental market in Turkey, where it currently
distributes and sells a range of dental anaesthetics and consumables to more
than 20,000 dental clinics.

Statistics indicate that 22 per cent of the Turkish population has advanced
periodontitis, representing a potential market of approximately nine million
people. Periostat will be the only enzyme suppression product on the market in
Turkey to treat periodontitis.

Alliance and Vem IIac have compiled and submitted the dossier to secure the
marketing authorisation for Periostat in Turkey. This registration process is
expected to take between eighteen months and two years.

Commenting on the news, John Dawson, Alliance Pharma's Chief Executive, said:
'I am extremely delighted with these two agreements. Periostat is a major growth opportunity for Alliance Pharma and this agreement with Vem IIac increases our international reach into a well developed dental market that represents a significant commercial opportunity. It has also produced a good understanding between us and CollaGenex on the way forward to exploit markets that were outside our original agreement.'

For further information:
Alliance Pharma plc + 44 (0) 1249 466966
John Dawson, Chief Executive
Maddy Scott, Finance Director

www.alliancepharma.co.uk

PpP: APH my No 2 candidate for top-up and after that news, for which thanks, I'd better get in quickly.
On VLK, yours was a timely posting yesterday, and I think I'll just hopefully enjoy the ride from here.
sd.

squidd yes I have topped up in VLK but I am stuck on which one is the next candidate as they are all at times when news, results or trend will move them higher so will have to sit down and think about this over the weekend.

squidd looking at those two big trades yesterday you might be getting some holdings increase news next week so very nicely timed buy if it is.

PpP: You were right about the new holdings. Have noted that Aviva, via their subsidiary Morley, have joined the stake holders, taking up 10% of APH. I'm glad that us ordinary mortals were able to clamber aboard ahead of the action.
sd.

squidd I knew something was going on then and its good news that comes through,will be adding more in the coming months.

PpP: I slept soundly yesterday morning as ULT climbed 50% until wakened by a call from a day trader friend, who urged me to sell. But after we talked about the various scenarios for the global roll out of ULT's CBT and a possible reaction from beleaguered pharmas, defending their tranquilliser pills, he agreed that I would have to buy back pdq, so I'm still in.
I hope that somewhere along the line people will recognise that APH's Posidorm is also a type of traquilliser, but being the body's own produce, is unlikely to have side effects.
sd.